ALFA Filings
Every announcement, straight from the exchange
Every Ambey Laboratories capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Dhansa Labs Limited allotted 3,63,043 equity shares following warrant conversions, raising ₹1.67 Crore. This exercise increases the company's paid-up capital and strengthens its equity base.
Dhansa Labs Limited allotted 3,60,870 equity shares following warrant conversions, totaling ₹1.66 Crore. This exercise increases the company's paid-up capital to ₹26.54 Crore.
Ambey Laboratories Limited allotted 3,63,043 equity shares following the conversion of warrants issued in August 2025. The company received the balance 75% payment aggregating to ₹1.25 Crore. Consequently, the paid-up share capital increased to 2,61,79,427 equity shares.
Dhansa Labs Limited (formerly Ambey Laboratories) allotted 3,63,043 equity shares following the conversion of warrants by Reema Pratit Patel. The company received ₹1.67 Crore representing the total issue price at ₹46 per share. Consequently, the company's paid-up equity share capital increased to ₹26.18 Crore.
Ambey Laboratories Limited has allotted 8,69,565 equity shares following the conversion of warrants. The company received a balance payment of ₹3.00 Crore (75% of the issue price) from two investors. The shares were issued at a price of ₹46 per share, including a ₹36 premium.
Ambey Laboratories Limited (now Dhansa Labs Limited) allotted 8,69,565 equity shares upon the conversion of warrants. The company received Rs. 3.00 Crore as the final 75% payment for these shares. Following this allotment, the company's paid-up equity capital increased to Rs. 25.82 Crore, with 1,00,00,000 warrants remaining outstanding.